Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.
Ishihara L, Warren L, Gibson R, Amouri R, Lesage S, Dürr A, Tazir M, Wszolek ZK, Uitti RJ, Nichols WC, Griffith A, Hattori N, Leppert D, Watts R, Zabetian CP, Foroud TM, Farrer MJ, Brice A, Middleton L, Hentati F.
Ishihara L, et al. Among authors: brice a.
Arch Neurol. 2006 Sep;63(9):1250-4. doi: 10.1001/archneur.63.9.1250.
Arch Neurol. 2006.
PMID: 16966502